Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH reports net income of $1.91 million in 9M 2017


According to the financial statements of  Jerusalem Pharmaceuticals JPH for the first nine months of 2017, Net profit after tax of the period reached 4,301,803 USD Compared with Net profit after tax 1,916,996 USD for 2016, a net increase in profit of 124.40%.Total assets of the company reached 60,808,624 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 14.80%.Total liabilities of the company reached 15,226,263 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net increase of 19.79%. Net ownership equity of the company reached 45,582,361 USD (Including Non-Controlling Interests of 525,788 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 13.22%.


launching 3G mobile networks in the west bank by the end of January

Relative quietness in the PEX with the increasing anticipation for the annual disclosures

WATANIYA discusses raising its paid-up capital to $293 million

The PEX opens the year 2018 in optimism

The PEX modifies AL-Quds Index composition for the year 2018



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013